Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Progression”

202 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 202 results

Not applicableUnknownNCT02379208
What this trial is testing

Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Turku University Hospital 60
Large-scale testing (Phase 3)Study completedNCT01544192
What this trial is testing

Impact of Oral Versatile Antioxidants on Glaucoma Progression

Who this might be right for
Glaucoma
Bagcilar Training and Research Hospital 60
Post-approval studies (Phase 4)Study completedNCT00153972
What this trial is testing

Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Technische Universität Dresden 39
Not applicableStudy completedNCT05223504
What this trial is testing

WARD-Home - Continuous Monitoring of Vital Parameters After Discharge

Who this might be right for
Vital SignClinical Deterioration
Rigshospitalet, Denmark 80
Not applicableActive Not RecruitingNCT05698316
What this trial is testing

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

Who this might be right for
Age Related Macular DegenerationIntermediate AMDAtrophy+1 more
Association for Innovation and Biomedical Research on Light and Image 1,000
Not applicableNot Yet RecruitingNCT07503366
What this trial is testing

Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies

Who this might be right for
Type 1 Diabetes (T1D)AutoantibodiesHyperglycemia+1 more
Società Italiana di Endocrinologia e Diabetologia Pediatrica 300
Testing effectiveness (Phase 2)UnknownNCT04305002
What this trial is testing

Exenatide Treatment in Parkinson's Disease

Who this might be right for
Parkinson Disease
Center for Neurology, Stockholm 60
Not applicableLooking for participantsNCT04370730
What this trial is testing

Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

Who this might be right for
SchizophreniaPsychotic Disorders
Assistance Publique - Hôpitaux de Paris 200
Not applicableUnknownNCT02352220
What this trial is testing

Determinants of Onset and Progression of COPD in Young Adults

Who this might be right for
COPD
Borja Cosio 310
Large-scale testing (Phase 3)Active Not RecruitingNCT04964934
What this trial is testing

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

Who this might be right for
ER-Positive HER2-Negative Breast Cancer
AstraZeneca 315
Not applicableLooking for participantsNCT07038967
What this trial is testing

Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification

Who this might be right for
Non-CenterDiabetic Macular EdemaPhacoemulsification
Ain Shams University 50
Not applicableStudy completedNCT05650281
What this trial is testing

Silent Progression Activity Monitoring - SPAM Study

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nice 2,230
Not applicableStudy completedNCT05366725
What this trial is testing

Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

Who this might be right for
Urothelial Cancer
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 106
Large-scale testing (Phase 3)Not Yet RecruitingNCT06587347
What this trial is testing

Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke

Who this might be right for
Acute StrokeIschemic Stroke, AcuteCerebral Infarction
Capital Medical University 302
Not applicableLooking for participantsNCT04622462
What this trial is testing

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Who this might be right for
Oral Neoplasm
Proteocyte Diagnostics Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT04388683
What this trial is testing

Inhaled Nitric Oxide for Preventing Progression in COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06694454
What this trial is testing

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00000600
What this trial is testing

Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up

Who this might be right for
Cardiovascular DiseasesCarotid Artery DiseasesIntracranial Arteriosclerosis+4 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT03910777
What this trial is testing

Usefulness of Early Warning Systems in Detecting Early Clinical Deterioration After Intensive Care Discharge

Who this might be right for
Early Clinical DeteriorationEarly Warning Score
Erzincan University 390
Not applicableUnknownNCT00464594
What this trial is testing

Japan Early Diabetes Intervention Study

Who this might be right for
Diabetes Mellitus
Japan Early Diabetes Intervention Study Group 2,560
Load More Results